Considerations for cancer immunotherapy during the COVID-19 pandemic

Yada Kanjanapan; Desmond Yip

doi:10.5694/mja2.50805

Considerations for cancer immunotherapy during the COVID-19 pandemic

Yada Kanjanapan^*, Desmond Yip

^*Corresponding author for this work

School of Medicine and Psychology

Research output: Contribution to journal › Comment/debate › peer-review

3 Citations (Scopus)

Abstract

Cancer immunotherapy during the COVID-19 pandemic presents management challenges related to immune-related toxicities, requiring careful patient selection.

Original language	English
Pages (from-to)	390-392.e1
Journal	Medical Journal of Australia
Volume	213
Issue number	9
DOIs	https://doi.org/10.5694/mja2.50805
Publication status	Published - 1 Nov 2020

Access to Document

10.5694/mja2.50805

Cite this

@article{2814b196b09d4a2094163c7cc9128e7b,

title = "Considerations for cancer immunotherapy during the COVID-19 pandemic",

abstract = "Cancer immunotherapy during the COVID-19 pandemic presents management challenges related to immune-related toxicities, requiring careful patient selection.",

keywords = "COVID-19, Cancer, Immunotherapies, Infectious diseases, Respiratory tract infections",

author = "Yada Kanjanapan and Desmond Yip",

year = "2020",

month = nov,

day = "1",

doi = "10.5694/mja2.50805",

language = "English",

volume = "213",

pages = "390--392.e1",

journal = "Medical Journal of Australia",

issn = "0025-729X",

publisher = "John Wiley \& Sons Inc.",

number = "9",

}

TY - JOUR

T1 - Considerations for cancer immunotherapy during the COVID-19 pandemic

AU - Kanjanapan, Yada

AU - Yip, Desmond

PY - 2020/11/1

Y1 - 2020/11/1

N2 - Cancer immunotherapy during the COVID-19 pandemic presents management challenges related to immune-related toxicities, requiring careful patient selection.

AB - Cancer immunotherapy during the COVID-19 pandemic presents management challenges related to immune-related toxicities, requiring careful patient selection.

KW - COVID-19

KW - Cancer

KW - Immunotherapies

KW - Infectious diseases

KW - Respiratory tract infections

UR - https://www.scopus.com/pages/publications/85092196306

U2 - 10.5694/mja2.50805

DO - 10.5694/mja2.50805

M3 - Comment/debate

SN - 0025-729X

VL - 213

SP - 390-392.e1

JO - Medical Journal of Australia

JF - Medical Journal of Australia

IS - 9

ER -

Considerations for cancer immunotherapy during the COVID-19 pandemic

Abstract

Access to Document

Other files and links

Fingerprint

Cite this